Nanobiotix (NBTX) Short term Debt (2018 - 2025)

Nanobiotix's Short term Debt history runs 8 years deep, the most recent figure standing at $5.0 million for Q4 2025.

• On a quarterly basis, Short term Debt fell 4.67% year-over-year to $5.0 million in Q4 2025; TTM through Dec 2025 was $5.0 million, a 4.67% decrease from a year earlier, with the FY2025 full-year figure at $4.9 million, down 7.48% from the prior year.
• Short term Debt retreated to $5.0 million in Q4 2025 per NBTX's latest filing, from $5.4 million in the prior quarter.
• Across five years, Short term Debt topped out at $10.9 million in Q2 2023 and bottomed at $4.7 million in Q4 2022.
• The 5-year median for Short term Debt is $5.4 million (2023), against an average of $6.9 million.
• Across the five-year window, Short term Debt surged 61.57% in 2021 and tumbled 50.43% in 2022, its largest moves.
• Year by year, Short term Debt stood at $9.4 million in 2021, then plunged by 50.43% to $4.7 million in 2022, then increased by 16.14% to $5.4 million in 2023, then dropped by 2.62% to $5.3 million in 2024, then dropped by 4.67% to $5.0 million in 2025.
• Per Business Quant, the three latest NBTX Short term Debt figures stand at $5.0 million (Q4 2025), $5.4 million (Q2 2025), and $5.3 million (Q4 2024).